67e287ec12ea8.pdf
DOI:
Mavjud emas
1.Ўзбекистон Республикаси Давлат Фармакопеяси Iжилд, 1-,2-ва 3-қисмлар.-Тошкент.-2022. 1019-б.2.Илхaмовa Н.Б., Джaлилов Х.К., Юнусовa Х.М. //«Ибуaсктaмол», «Ниме-S» вa «Ибупрофен-S» тaблеткaлaрини сифaт кўрсaткичлaрини ўргaниш// Фaрмaцевтикa журнaли.-Тaшкент.-2016.-No4.-Б.52-57.3.Ilkhamova N.B., Djalilov H.K. // Research on the development of technology effervescent tablets «Antigrippin-«SAMO» // American journal of science and technologies.-Princeton University press.-2016.-No1(21).-P.1029-10344.Yunusova Kh.M., Jaloliddinova M.Sh. Studying pharmacotechnological aspects and stability of “Ortof-S” tablets // World journal of pharmacy and pharmaceutical sciences.-2019.-Vol.-8.-Issue 1.-P. 277-288. (RG=0,13; SJIF Impact Factor 7.421).5.Шодиевa Н.Б., Юнусовa Х.М., Aхмедовa Д.Т. Cтaндaртизaция тaблеток «Пирaцетaм по 0,2 и 0,4г» // Инфекция, Иммунитет и Фaрмaкология.-Тошкент.-2016-No6.-Б.499-502. 6.Abdijalilova Z.Kh., Yunusova Kh.M., Ilkhamova N.B. Pre-clinical study of expectorant properties of «Ambrol» tablets. // International Journal of Psychosocial Rehabilitation, Vol. 24, Issue 04, 2020.-Р.2349-2354.7.Жалолиддинова М.Ш., Юнусова Х.М. “Дикомз” капсуласининг сифатини баҳолаш // Ўзбекистон фармацевтик хабарномаси.-Тошкент.-2018.-No4.-Б.75-79.8.Abdijalilova Z.Kh., Yunusova Kh.M. Study of influence of technological factors on indicators of 9.quality of tablets of secrolitic action // World journal of pharmacy and pharmaceutical sciences.-10.2020.-Vol.-9. Issue 1,-P.373-380. (RG=0,13; SJIF Impact Factor 7.632).11.Shodieva N.B., Yunusova Kh.M. Study influencing factors in quality for recommended tablets "Piracetam"// British journal of educational and scientific studies.-Imperial college press.-2016.-No1(23).-P.845-850 (Scopus SNIP –5,7960, SJR-5,925).12.Yunusova X.M., Turdiyeva Z.V., Anvarova.F.J. Research on the development of the specific composition and technology of the "Sedtab" tablet.//International Journal of Current Science Research and Review ISSN: 2581-8341 Volume 07 Issue 02 February 2024 DOI: 10.47191, Impact Factor: 7.943 P. 1050-1056.